Exploring the Active Components and Mechanism of Xiao’er Qingjie Fanggan Granule in the Preventionand Treatment of Influenza A

Ma Li; Song Yanping; Zhao Lintao; Zeng Ju; Guo Qian; Qiao Yuan

doi:10.13407/j.cnki.jpp.1672-108X.2023.04.001

您当前的位置：

首页 >

文章列表页 >

Exploring the Active Components and Mechanism of Xiao’er Qingjie Fanggan Granule in the Preventionand Treatment of Influenza A

更新时间：2023-04-28

- Exploring the Active Components and Mechanism of Xiao’er Qingjie Fanggan Granule in the Preventionand Treatment of Influenza A
- Vol. 29, Issue 4, Pages: 1-6(2023)
- 作者机构：
  
  1. 陕西中医药大学,陕西,咸阳,712046
  2. 陕西省中医药研究院,西安,710003
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2023.04.001
  CLC：
- Published：2023，
扫描看全文
Ma Li, Song Yanping, Zhao Lintao, et al. Exploring the Active Components and Mechanism of Xiao’er Qingjie Fanggan Granule in the Preventionand Treatment of Influenza A. [J]. 29(4):1-6(2023)
DOI：

Ma Li, Song Yanping, Zhao Lintao, et al. Exploring the Active Components and Mechanism of Xiao’er Qingjie Fanggan Granule in the Preventionand Treatment of Influenza A. [J]. 29(4):1-6(2023) DOI： 10.13407/j.cnki.jpp.1672-108X.2023.04.001.

摘要

目的:揭示小儿清解防感颗粒防治甲型流感(甲流)的活性成分、靶点信息及作用机制。方法:通过中药系统药理学数据库与分析平台(TCMSP)等数据库筛选小儿清解防感颗粒的潜在活性成分

利用PubChem 和Swiss Target Prediction 预测潜在靶点

并与GeneCards 等数据库收集的甲流基因映射;String 数据库构建蛋白互作网络

Cytoscape 3. 7. 2 软件构建药物-活性成分- 核心靶点-疾病网络

Metascape 进行KEGG 通路富集分析;Autodock Vina 和Pymol 软件进行分子对接及可视化。结果:木犀草素等158 种活性成分作用于AKT1 等321 个靶点

进而调控甲流202 条信号通路。与奥司他韦相比

木犀草素等与NS1 蛋白有更强的结合力。结论:小儿清解防感颗粒可能是通过参与直接抗甲流病毒、调节免疫和抑制炎症反应等生物过程对甲流发挥防治作用的。

Abstract

Objective: To reveal the active ingredients

targets

and mechanism of Xiao’er Qingjie Fanggan granule in the prevention and treatment of influenza A. Methods: The potential active ingredients of Xiao’er Qingjie Fanggan granule were screened by Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and the Encyclopedia of Traditional Chinese Medicine (ETCM) database. The targets were obtained by PubChem and Swiss Target Prediction

which mapped to the influenza A related targets. The protein-protein interaction (PPI) network was constructed by String database

and the herb-component-target-pathway network was constructed by Cytoscape 3. 7. 2

then the enrichment of KEGG pathway was analyzed by Metascape. Finally

the binding activity of the key components to the core targets were verified by molecular docking and visualization through Autodock Vina and Pymol. Results: Luteolin and other 158 active ingredients acted on 321 targets such as AKT1

and then regulated 202 signaling pathways. Compared with oseltamivir

luteolin and other active ingredients had stronger binding force on NS1

which was the binding protein of influenza A. Conclusion: Xiao’er Qingjie Fanggan granule may play a role in protection against influenza A by participating in biological processes such as direct protection against influenza A viruses

modulation of immunity and suppression of inflammatory responses.

关键词

小儿清解防感颗粒甲型流感网络药理学分子对接作用机制

Keywords

Xiao’er Qingjie Fanggan granulenfluenza Anetwork pharmacologymolecular dockingmechanism

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Mechanism of the Core Drugs of Changju Zhidong Prescription in the Treatment of Tic Disorders Based on

Mechanism of Dingchuan Decoction in the Treatment of Cough Variant Asthma Based on Network Pharmacology and Molecular Docking Technology

Exploration of Medication Rules and Core Mechanism of Traditional Chinese Medicine in the Treatment of Adenoidal Hypertrophy Based on Data Mining and Network Pharmacology

Active Ingredients and Mechanism of Yinlai Decoction in the Treatment of Children with Pneumonia Based on System Pharmacology

Mechanism of Schisandra Chinensis in the Treatment of Inflammatory Bowel Disease Based on Network Pharmacology

Related Author

Li Yuan

Cheng Shuang

Sun Ting

Zhang Qiang

Wang Junhong

Liu Yuan

Zhai Rui

Fang Shunshun

Related Institution

Dongzhimen Hospital,Beijing University of Chinese Medicine, Beijing　100700, ChinaBeijing University of Chinese Medicine, Beijing

Dongzhimen Hospital, Beijing University of Chinese Medicine

Guanggu District, Wuhan Third Hospital

College of Pharmacy, Liaoning University of Traditional Chinese Medicine

Haian Hospital of Nantong University, Jiangsu Hai’an

⁰